ArticleFrontiers in immunology2022

Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment.

Suxia Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.